CNTX
Context Therapeutics Inc. Common Stock
PHARMACEUTICAL PREPARATIONS
Best Pharmaceutical Stocks 2026 →
Context Therapeutics (CNTX) Stock: Buy, Sell, or Hold?
$0.19
-0.01 (-6.64%)
▼
5d:
-3.61%
30d:
-38.69%
90d:
-60.2%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (77%)
Quality Score
42/100
Position
OVERSOLD
30-Day Fair Range
$0.21 – $0.30
Position: OVERSOLD
Forward P/E & Valuation
-0.4x
Next 12M consensus est.
Wall Street Target
$4.14
+2115.5% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$0.18 / $0.24
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 MIXED SIGNALS: CNTX shows conflicting indicators. Wait for confirmation before entering.
Get Alerted When CNTX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: CNTX is currently trading at $0.19, which is considered oversold relative to its 30-day fair value range of $0.21 to $0.30.
Technical Outlook: Technically, CNTX is in a strong downtrend. Immediate support is located at $0.18, while resistance sits at $0.24. Short-term momentum is weak, with the stock down 6.6% recently.
Market Sentiment: The stock scores a mixed 58/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $4.14 (+2115.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CNTX is in a strong downtrend. Immediate support is located at $0.18, while resistance sits at $0.24. Short-term momentum is weak, with the stock down 6.6% recently.
Market Sentiment: The stock scores a mixed 58/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $4.14 (+2115.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.21 -
$0.30
Company Quality Score
42/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
77.4%
Trading Range & Key Levels
30-Day Trading Range
$0.21 -
$0.30
Current vs Trading Range
OVERSOLD
Support Level
$0.18
Resistance Level
$0.24
Current Trend
Strong Downtrend
Technical data as of
Nov 10, 2026
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (58/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-6.6%)
- BULLISH: Trading 2115.5% below Wall St target ($4.14)
- WARNING: Composite score 42/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-0.43
Wall Street Target
$4.14
(+2115.5%)
Share CNTX Analysis
Share this live CNTX analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (CNTX)
Bullish
1 Retail Mentions
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 11, 2026
Daily AI digest
AI Retail Discussion Summary:
Context Therapeutics reported promising results from its Phase 1 trial of CTIM-76 in platinum-resistant ovarian cancer, with promising efficacy, tolerability, and dose-proportional cytokine release.
Key Retail Themes:
Phase 1 trial results
Dose-proportional cytokine release
T cell activation and tumor shrinkage
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 1:16 AM ET
Data refreshes hourly during market hours. Next update: 2:16 AM
Data refreshes hourly during market hours. Next update: 2:16 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CNTX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
WVE
Wave Life Sciences Ltd |
STRONG BUY
21 analysts |
$17 | 43 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
20 analysts |
$36 | 37 SELL |
|
SRRK
Scholar Rock Holding Corp |
STRONG BUY
18 analysts |
$70 | 39 SELL |
|
ARWR
Arrowhead Pharmaceutical… |
STRONG BUY
15 analysts |
$108 | 47 HOLD |
|
MIRM
Mirum Pharmaceuticals Inc |
STRONG BUY
14 analysts |
$155 | 45 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive CNTX Research Pages
